These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11696814)

  • 1. Reactive stroma in prostate cancer progression.
    Tuxhorn JA; Ayala GE; Rowley DR
    J Urol; 2001 Dec; 166(6):2472-83. PubMed ID: 11696814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
    Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
    Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
    Ayala G; Tuxhorn JA; Wheeler TM; Frolov A; Scardino PT; Ohori M; Wheeler M; Spitler J; Rowley DR
    Clin Cancer Res; 2003 Oct; 9(13):4792-801. PubMed ID: 14581350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the stromal microenvironment in prostate cancer.
    Condon MS
    Semin Cancer Biol; 2005 Apr; 15(2):132-7. PubMed ID: 15652458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
    Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of prostate cancer growth in bone microenvironments.
    Edlund M; Sung SY; Chung LW
    J Cell Biochem; 2004 Mar; 91(4):686-705. PubMed ID: 14991761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate.
    Zhang Y; Nojima S; Nakayama H; Jin Y; Enza H
    Oncol Rep; 2003; 10(1):207-11. PubMed ID: 12469170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model.
    Tuxhorn JA; McAlhany SJ; Yang F; Dang TD; Rowley DR
    Cancer Res; 2002 Nov; 62(21):6021-5. PubMed ID: 12414622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma.
    Tomas D; Kruslin B
    Prostate; 2004 Dec; 61(4):324-31. PubMed ID: 15389817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the tumor stroma as a novel therapeutic approach for prostate cancer.
    Franco OE; Hayward SW
    Adv Pharmacol; 2012; 65():267-313. PubMed ID: 22959029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix secreted by reactive stroma is a main inducer of pro-tumorigenic features on LNCaP prostate cancer cells.
    Palumbo A; Ferreira LB; Reis de Souza PA; Oliveira FL; Pontes B; Viana NB; Machado DE; Palmero CY; Alves LM; Gimba ER; Nasciutti LE
    Cancer Lett; 2012 Aug; 321(1):55-64. PubMed ID: 22388175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
    J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.